25 May 2016
New Phase 3 Study Findings Show STELARA® Maintained Clinical Remission after One Year of Treatment in Patients with Moderate to Severe Crohn’s Disease
SAN DIEGO, May 23, 2016: Janssen Research & Development, LLC (Janssen) Phase 3 data presented for the first time at Digestive Disease Week® 2016 showed…